Recent patents in the discovery of small molecule inhibitors of JAK3
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543771003709767
Reference18 articles.
1. Jaks and Stats in signaling by the cytokine receptor superfamily
2. Therapeutic targeting of Janus kinases
3. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction.
4. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene
5. Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking;Molecular Diversity;2024-07-15
2. Machine Learning-Driven Predictions for Janus Kinase 3 Protein Drug Effectiveness;2024 IEEE First International Conference on Artificial Intelligence for Medicine, Health and Care (AIMHC);2024-02-05
3. Discovery of JAK2/3 Inhibitors from Quinoxalinone-Containing Compounds;ACS Omega;2022-09-07
4. Phenolic compounds from the insect Blaps japanensis with inhibitory activities towards cancer cells, COX-2, ROCK1 and JAK3;Tetrahedron;2019-02
5. Discovery of tricyclic dipyrrolopyridine derivatives as novel JAK inhibitors;Bioorganic & Medicinal Chemistry;2017-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3